Author response for "Historic real-world outcomes and future benchmarks for patients with diffuse large B-cell lymphoma receiving first- and second-line therapy in Austria – a large single-center experience"Michael Leisch, Thomas Melchardt, Dominik Kiem et al.|Unknown|2025Cited by 0
Glofitamab in Heavily Pretreated Mantle Cell Lymphoma Patients: A Multicenter Real‐World Case SeriesNatalia Rotter, Thomas Melchardt, Olga Saini et al.|eJHaem|2026Cited by 0